Invention Grant
- Patent Title: Humanized monoclonal antibodies that target VE-PTP (HPTP-β)
-
Application No.: US16775860Application Date: 2020-01-29
-
Publication No.: US11136389B2Publication Date: 2021-10-05
- Inventor: Kevin Peters , Michael Allen Flynn
- Applicant: AERPIO PHARMACEUTICALS, INC.
- Applicant Address: US OH Cincinnati
- Assignee: AERPIO PHARMACEUTICALS, INC.
- Current Assignee: AERPIO PHARMACEUTICALS, INC.
- Current Assignee Address: US OH Cincinnati
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C07K16/22 ; A61K39/00
Abstract:
The disclosure provides compositions and methods for the treatment of ocular conditions associated with angiogenesis comprising administering an antibody that targets a tyrosine phosphatase inhibitor in a subject.
Public/Granted literature
- US20200239567A1 HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta) Public/Granted day:2020-07-30
Information query
